MetLife Announces New $3 Billion Share Repurchase Authorization
MetLife Announces New $3 Billion Share Repurchase Authorization
MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $400 million remaining under the company’s prior authorization announced in April 2025.
“This new share repurchase authorization reflects our confidence in MetLife’s long-term outlook and continued ability to generate capital,” said MetLife President and Chief Executive Officer Michel Khalaf. “Our diversified business portfolio, financial strength and disciplined execution continue to support durable growth and attractive returns. Consistent with our New Frontier strategy, we remain committed to deploying capital where it creates the greatest long-term value for shareholders.”
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.
Forward-Looking Statements
The forward-looking statements in this news release, using words such as “confidence,” “continue,” “durable,” “long-term,” and “remain” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.
For Media:
Steve LaMarca
646-884-3840
Steve.LaMarca@metlife.com
For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260805336465/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States